Rami Katkhuda
Stock Analyst at LifeSci Capital
(4.84)
# 400
Out of 4,408 analysts
303
Total ratings
51.4%
Success rate
27.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rami Katkhuda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRON Disc Medicine | Maintained: Buy | $100 | $70.09 | +42.67% | 38 | Jun 15, 2026 | |
| MLTX MoonLake Immunotherapeutics | Maintained: Buy | $33 | $19.19 | +71.96% | 40 | Jun 15, 2026 | |
| DNTH Dianthus Therapeutics | Rated: Buy | $125 | $82.47 | +51.57% | 23 | Jun 12, 2026 | |
| ELDN Eledon Pharmaceuticals | Maintained: Buy | $6 | $3.43 | +74.93% | 39 | Jun 8, 2026 | |
| JBIO Jade Biosciences | Maintained: Buy | $42 | $16.10 | +160.87% | 4 | Jun 6, 2026 | |
| VERA Vera Therapeutics | Maintained: Buy | $90 | $34.24 | +162.85% | 36 | Jun 2, 2026 | |
| MLYS Mineralys Therapeutics | Rated: Buy | $54 | $23.92 | +125.75% | 24 | Jun 1, 2026 | |
| AMLX Amylyx Pharmaceuticals | Maintained: Buy | $24 | $15.19 | +58.00% | 13 | May 16, 2026 | |
| MAZE Maze Therapeutics | Maintained: Buy | $57 | $24.27 | +134.86% | 6 | May 16, 2026 | |
| VRDN Viridian Therapeutics | Maintained: Buy | $35 | $16.30 | +114.72% | 46 | May 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $3.76 | +272.34% | 12 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.622 | - | 22 | Aug 14, 2025 |
Disc Medicine
Jun 15, 2026
Maintained: Buy
Price Target: $100
Current: $70.09
Upside: +42.67%
MoonLake Immunotherapeutics
Jun 15, 2026
Maintained: Buy
Price Target: $33
Current: $19.19
Upside: +71.96%
Dianthus Therapeutics
Jun 12, 2026
Rated: Buy
Price Target: $125
Current: $82.47
Upside: +51.57%
Eledon Pharmaceuticals
Jun 8, 2026
Maintained: Buy
Price Target: $6
Current: $3.43
Upside: +74.93%
Jade Biosciences
Jun 6, 2026
Maintained: Buy
Price Target: $42
Current: $16.10
Upside: +160.87%
Vera Therapeutics
Jun 2, 2026
Maintained: Buy
Price Target: $90
Current: $34.24
Upside: +162.85%
Mineralys Therapeutics
Jun 1, 2026
Rated: Buy
Price Target: $54
Current: $23.92
Upside: +125.75%
Amylyx Pharmaceuticals
May 16, 2026
Maintained: Buy
Price Target: $24
Current: $15.19
Upside: +58.00%
Maze Therapeutics
May 16, 2026
Maintained: Buy
Price Target: $57
Current: $24.27
Upside: +134.86%
Viridian Therapeutics
May 9, 2026
Maintained: Buy
Price Target: $35
Current: $16.30
Upside: +114.72%
Mar 31, 2026
Maintained: Buy
Price Target: $14
Current: $3.76
Upside: +272.34%
Aug 14, 2025
Maintained: Hold
Price Target: n/a
Current: $0.622
Upside: -